Lifecore Biomedical, Inc.
LFCR
$7.90
$0.070.89%
NASDAQ
| 09/30/2025 | 05/25/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -14.64% | 3.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.64% | 3.67% | |||
| Cost of Revenue | 3.81% | -11.25% | |||
| Gross Profit | -44.28% | 42.02% | |||
| SG&A Expenses | -0.95% | -11.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.88% | -10.42% | |||
| Operating Income | -205.80% | 226.43% | |||
| Income Before Tax | -766.97% | 92.46% | |||
| Income Tax Expenses | 909.09% | 512.50% | |||
| Earnings from Continuing Operations | -771.05% | 92.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -771.05% | 92.23% | |||
| EBIT | -205.80% | 226.43% | |||
| EBITDA | -122.56% | 2,317.97% | |||
| EPS Basic | -427.67% | 88.22% | |||
| Normalized Basic EPS | -169.90% | 55.96% | |||
| EPS Diluted | -427.67% | 88.23% | |||
| Normalized Diluted EPS | -169.90% | 55.96% | |||
| Average Basic Shares Outstanding | 1.07% | -0.03% | |||
| Average Diluted Shares Outstanding | 1.07% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||